Iberogast™ recommended for the treatment of functional dyspepsia

Rome Foundation recognizes Bayer’s herbal medicine and provides guidance on the diagnosis and management of functional gastrointestinal disorders

Bayer addresses challenges in the citrus industry with a holistic approach

Integrated portfolio to prevent devastating disease citrus greening from spreading / Joining forces with private and public partners to address key challenges

Bayer and Monsanto to Create a Global Leader in Agriculture

Bayer and Monsanto to Create a Global Leader in Agriculture

Realizes a shared vision of integrated agricultural offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of farming / USD 128 per share in all-cash transaction, represents 44 percent premium to Monsanto shareholders and an aggregate value of USD 66 billion / Significant value creation with expected annual synergies of approximately USD 1.5 billion after year three; plus additional synergies from integrated solutions in future years / Bayer shareholders expected to benefit from accretion to core EPS in the first full year after closing and double-digit percentage accretion in the third full year / Committed to retaining strong presence in the U.S. with the combined business’ global Seeds & Traits and North American commercial headquarters in St. Louis